These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17192875)

  • 1. TGFBR3 loss and consequences in prostate cancer.
    Sharifi N; Hurt EM; Kawasaki BT; Farrar WL
    Prostate; 2007 Feb; 67(3):301-11. PubMed ID: 17192875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
    Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
    Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of TGFBR3 in bladder cancer.
    Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
    Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prostasin expression and function in the prostate.
    Chen LM; Zhang X; Chai KX
    Prostate; 2004 Apr; 59(1):1-12. PubMed ID: 14991861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells.
    Liu W; Wu Z; Guan M; Lu Y
    Int J Urol; 2009 Mar; 16(3):323-8. PubMed ID: 19207613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.
    Zhao H; Kim Y; Wang P; Lapointe J; Tibshirani R; Pollack JR; Brooks JD
    Prostate; 2005 May; 63(2):187-97. PubMed ID: 15486987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
    Hempel N; How T; Dong M; Murphy SK; Fields TA; Blobe GC
    Cancer Res; 2007 Jun; 67(11):5231-8. PubMed ID: 17522389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
    Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
    Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.
    Narita S; Tsuchiya N; Saito M; Inoue T; Kumazawa T; Yuasa T; Nakamura A; Habuchi T
    Prostate; 2008 Feb; 68(3):321-35. PubMed ID: 18175332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expressional changes in prostate fibroblasts from cancerous tissue.
    Reinertsen T; Halgunset J; Viset T; Flatberg A; Haugsmoen LL; Skogseth H
    APMIS; 2012 Jul; 120(7):558-71. PubMed ID: 22716211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
    Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
    Wang D; Lu S; Dong Z
    Prostate; 2007 Dec; 67(16):1825-33. PubMed ID: 17941092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma.
    Fritzsche S; Kenzelmann M; Hoffmann MJ; Müller M; Engers R; Gröne HJ; Schulz WA
    Endocr Relat Cancer; 2006 Sep; 13(3):839-49. PubMed ID: 16954433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
    Sigala S; Bodei S; Missale C; Zani D; Simeone C; Cunico SC; Spano PF
    Mol Cell Endocrinol; 2008 Mar; 284(1-2):11-20. PubMed ID: 18280641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.